The scenario with regard to veterinary molecular diagnostics market is destined for good buoyancy between 2025 and 2035 institutions and is expected to have a considerable amount of increasing demand owing to awareness on animal health and later through surveillance of zoonotic diseases, in addition to the widespread acceptance of innovative diagnostic approaches in that line of health care for companion animals and livestock species.
While serving for pathogen, genetic conditions, and drug-resistant infection detection in animals, molecular diagnostics are a group of techniques that include PCR, microarrays, and next-generation sequencing.
Because of increased pet ownership, livestock disease control, and the requirements to curb the misuse of antibiotics, there is a demand for accurate and quick point-of-care veterinary diagnostics. The market growth is further fueled by government schemes, food safety regulations, and veterinary research funding.
The veterinary molecular diagnostics market is projected to grow at a CAGR of 6.6%, rising from USD 236.8 million in 2025 to approximately USD 448.7 million by 2035.
Key Market Metrics
| Metric | Value |
|---|---|
| Market Size in 2025 | USD 236.8 Million |
| Projected Market Size in 2035 | USD 448.7 Million |
| CAGR (2025 to 2035) | 6.6% |
Being home to the highest rates of pet ownership, progressive veterinary treatment, and well-established livestock surveillance programs, North America contributes significantly to the veterinary molecular diagnostics market.
The USA is the leading nation in the applications of PCR and real-time diagnostics with respect to diseases in dogs, cats, poultry, and cattle. As explained above by WHO on the importance of early detection of emergent zoonotic diseases, along with common genetic conditions in pets and livestock, the One Health approach brings North America into the strategic center of innovation for veterinary diagnostics.
The market is buoyed in Europe by tight animal welfare standards, good veterinary health care systems, and public funding to improve the control of zoonotic diseases. Countries like Germany, the UK, and France are already pursuing molecular tests for livestock disease screening and food chain traceability, as well as diagnostics for companion animals.
According to WHO, the efforts that European nations lay into antimicrobial stewardship and disease surveillance of animals, constitute foundations upon which molecular diagnostics are built for veterinary practice and research.
Asia- Pacific is said to be the fastest-growing continent with demand for safe protein from animal sources, pet ownership, and investment by the government in veterinary infrastructure. Best development for molecular tests in asean and non-asean countries has been developed in leading markets such as China, India and Japan, that include avian flu, bluetongue, foot-and-mouth disease, brucellosis, and other emerging zoonoses.
Field kits will also produce for access to towns and establish mobile vet labs in this region. According to UN data, livestock are mostly located in this region, thus providing that framework through which to manage disease risk in this region.
High cost of molecular testing, limited infrastructure especially in rural areas, and shortage of competent workforce
Despite the ever-increasing demand, veterinary molecular testing is very expensive and out of reach for many small clinics or farms with a limited number of livestock. Laboratory infrastructure is inadequate in many regions, but mainly in terms of cold-chain dependent PCR and NGS based platforms.
There is, therefore, continued technologic restrain of adoption due to the shortage of trained veterinary molecular biologists as well as diagnostic technicians. WHO has stated that capacity building through improved veterinary laboratories and a trained workforce is vital for zoonotic disease control and early outbreak response.
Zoonotic surveillance, portable diagnostics, and livestock genomics
Better opportunities were opened for veterinary molecular diagnostics with the global drive around One Health and the prevention of disease caused through zoonosis. These had resulted in funding of molecular surveillance for diseases such as rabies, avian influenza, or African swine fever by national governments and international health agencies.
In the areas of clinical and field point-of-care testing, portable PCR analyzers, isothermal amplification devices, and lab-on-chip platforms have seen further developments. Furthermore, under the auspices of breeding programs such as the International Institute for Animal Health, molecular diagnostics have also been used for assessing disease resistance and wellness testing for companion animals. WHO states that early molecular detection of animal diseases aids in the prevention of cross-species transmission and in safeguarding global health.
Between 2020 and 2024, the veterinary diagnostics market increased investments due to the exposure of animal origin viruses in COVID-19 as increasing attention heightened disease tracking and food safety. Tests by PCR for zoonotic viruses and respiratory pathogens are more frequently seen veterinary settings.
From 2025 onward and into 2035, the market will evolve dramatically toward AI-interfaced diagnostic platforms, real-scale genomic screening of livestock, and decentralized testing models for farm and field use. Cross-sector collaboration between human and veterinary healthcare will continue to expand, with molecular diagnostics playing a central role in One Health data ecosystems.
Market Shifts: A Comparative Analysis (2020 to 2024 vs. 2025 to 2035)
| Market Shift | 2020 to 2024 Trends |
|---|---|
| Regulatory Landscape | Increased oversight on zoonotic testing |
| Consumer Trends | Focus on pet disease screening and biosecurity |
| Industry Adoption | Companion animal hospitals and livestock labs |
| Supply Chain and Sourcing | Reliance on centralized lab services |
| Market Competition | Led by established animal health companies |
| Market Growth Drivers | Pandemic-driven zoonotic risk awareness |
| Sustainability and Impact | Focus on outbreak response |
| Smart Technology Integration | Real-time PCR with cloud reporting |
| Sensorial Innovation | Swab-and blood-based collection |
| Market Shift | 2025 to 2035 Projections |
|---|---|
| Regulatory Landscape | Standardized One Health molecular diagnostics policies |
| Consumer Trends | Rise in preventative genomics and personalized veterinary care |
| Industry Adoption | Integration into agriculture biotech, breeding programs, and mobile clinics |
| Supply Chain and Sourcing | Growth of portable platforms and localized kit manufacturing |
| Market Competition | Entry of genomic testing startups and biotech service providers |
| Market Growth Drivers | Preventive livestock health, food security, and pet wellness diagnostics |
| Sustainability and Impact | Eco-friendly sample prep kits and low-waste field diagnostics |
| Smart Technology Integration | AI-guided diagnostics, genomic databases, and block chain -based traceability |
| Sensorial Innovation | Saliva-based, microfluidic, and at-home sample collection innovations |
As with most markets in the United States, the veterinary molecular diagnostics market is slowly developing. Increased pet ownership, heightened vigilance for livestock diseases, and rising demand for rapid, accurate diagnosis tools have been key factors drawing investments into the veterinary molecular diagnostics arena.
Mostly deployed to detect zoonotic diseases, parasitic infections, and genetic diseases in companion and farm animals, molecular techniques such as PCR, RT-PCR, and DNA sequencing have seen heavy use. The USA has made significant investments through the OECD in developing veterinary laboratory networks and biosecurity infrastructure and has made their operations smoother and faster in responding to any animal health threat. Their scope is further aided by expanding applications in precision animal health and herd management systems.
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 6.9% |
UK veterinary molecular diagnostics are thus given impetus by the government welfare initiatives that become accessory in animal health surveillance and disease eradication in livestock. The Animal and Plant Health Agency and the private laboratories are putting in place molecular modalities for both antimicrobial resistance surveillance and infections at farms.
Expansion of equine and companion animal care is driving demand for diagnostic innovation, particularly PCR-based testing, according to OECD. Rapid diagnostics for respiratory, dermatological and vector-borne diseases are being developed from collaborative efforts between veterinary colleges and biotech startups.
| Country | CAGR (2025 to 2035) |
|---|---|
| United Kingdom | 6.4% |
The EU veterinary molecular diagnostics market shows favorable development, particularly with the health safety regulation directed to agriculture, disease control programs, and public funding. Countries such as Germany, France, and the Netherlands are main consumers of the technologies, namely, PCR, qPCR, or next-generation sequencing (NGS), with regards to livestock and poultry health monitoring.
According to UN, the EU Food Safety Authority promotes molecular diagnostics for real-time disease tracing as well as antibiotic stewardship. An increasing awareness of zoonosis and traceability in food production from animals also drives the market.
| Country | CAGR (2025 to 2035) |
|---|---|
| European Union | 6.6% |
Emerging pet ownership and priority given by the Japanese veterinary molecular diagnostics market attention for food safety and emerging animal diseases control have brought the much-needed boost to this market. Molecular surveillance systems are being developed under the Japanese Ministry of Agriculture, Forestry and Fisheries for avian influenza, swine fever, and infectious diseases in companion animals.
As per OECD, high-welfare standards in veterinary services and the increasing care given to pets enhanced the adoption of real-time PCR and genetic panels. Domestic companies are also innovating multiplex testing platforms for point-of-care veterinary clinics.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 6.3% |
The veterinary molecular diagnostics market in South Korea is undergoing rapid development thanks to biosecurity programs funded by the government and the expanding veterinary diagnostic infrastructure. According to OECD, the authorities in Korea have increased genomic-based surveillance tools to cope with livestock disease emergencies, including zoonotic threats.
In such diagnosis, molecular assays for canine parvovirus, feline leukemia, and tick-borne diseases are now routine practice in veterinary clinics. Local diagnostic companies are developing portable PCR analyzers and kits perfectly adapted to both field and clinical diagnostics.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 6.8% |
The veterinary molecular diagnostics market is exhibiting a continuous trend as a result of the need for accurate and rapid diagnostic instruments in animal health care. The molecular diagnostics enable pathogen genetic material detection for early diagnosis and subsequent treatment of diseases in animals.
The market share globally in the various product types and end-user segments is dominated by PCR kit and veterinary hospital, and it is attributable to their higher sensitivity, specificity, and wide utilization in clinical settings. This will assist in the improved management of diseases, increased biosecurity, and continued development of veterinary medicine.
With the increasing prevalence of zoonotic diseases and intensifying need for accurate diagnostic methods, the PCR kit applicable in veterinary hospitals remains the centerpiece of any animal health and disease control advancement.
PCR kits dominate product use due to high sensitivity, rapid turnaround, and versatility in detecting a wide range of pathogens
| Product Type | Market Share (2025) |
|---|---|
| PCR Kits | 68.5% |
PCR kits command the veterinary molecular diagnostics market as they provide a reliable and efficient means of detecting particular genetic sequences of pathogens. For the most part, their convenience of use and applicability to numerous sample types would tremendously increase their use across various veterinary settings.
Veterinary hospitals dominate end user adoption due to comprehensive diagnostic capabilities, skilled personnel, and integration into routine animal health care
| End User | Market Share (2025) |
|---|---|
| Veterinary Hospitals | 66.2% |
Veterinary hospitals form the largest end-user segment in the veterinary molecular diagnostics market due to their diagnostic capabilities and availability of skilled veterinary workforce. In addition, molecular diagnostics applied into these routine animal health care practices would definitely result to accurate detection of the disease and effective treatment strategies.
The attraction towards veterinary hospitals is further enhanced by the fact that they also have the capacity of dealing with complicated cases and complex diagnostic procedures, as well as specialized levels of care and treatment. Such institutions will keep at pace with the advances in molecular diagnostic technologies since they are likely to be the ones that most require high-end veterinary services.
Veterinary molecular diagnostics market is marching much ahead basically being driven by the increasing awareness of zoonotic diseases, rising pet ownership, and also beefing up livestock health scrutiny across the globe. Several molecular diagnostic approaches such as PCR, qPCR, RT-PCR, and isothermal amplification find applications in the early and accurate detection of infectious agents affecting animals.
Using these tools, it is possible to rapidly identify pathogens, including viruses, bacteria, and parasites, in both pet animals and production animals. Elegantly enhancing veterinary responses to clinical, farm, and laboratory environments are such developments as point-of-care testing, the development of syndromic panels, and multiplex testing kits. According to WHO, early pathogen detection through veterinary diagnostics plays a prerequisite role globally to prevent zoonotic transmission to secure food systems.
Market Share Analysis by Key Players & Diagnostic Providers
| Company Name | Estimated Market Share (%) |
|---|---|
| IDEXX Laboratories, Inc. | 14-17% |
| Zoetis Inc. | 11-14% |
| Thermo Fisher Scientific | 9-12% |
| Bio-Rad Laboratories, Inc. | 7-10% |
| QIAGEN N.V. | 6-9% |
| Other Providers | 38-45% |
| Company Name | Key Offerings/Activities |
|---|---|
| IDEXX Laboratories, Inc. | In 2024, launched point-of-care PCR panels for canine vector-borne diseases in 2025, expanded diagnostic menu for feline retrovirus detection using real-time qPCR. |
| Zoetis Inc. | In 2024, enhanced VetScan Imagyst with AI-powered molecular interpretation in 2025, introduced livestock disease multiplex assays for global surveillance programs. |
| Thermo Fisher Scientific | In 2024, released real-time PCR assays targeting avian and bovine pathogens in 2025, developed mobile PCR platforms for veterinary field diagnostics. |
| Bio-Rad Laboratories, Inc. | In 2024, introduced droplet digital PCR kits for equine infectious diseases in 2025, integrated cloud-based results reporting into veterinary testing workflows. |
| QIAGEN N.V. | In 2024, expanded QIAstat-Dx panels to include companion animal pathogens in 2025, developed portable sample prep kits compatible with veterinary field settings. |
Key Market Insights
IDEXX Laboratories, Inc. (14-17%)
IDEXX leads in companion animal diagnostics with a broad portfolio of molecular tools for in-clinic and reference lab use. Its PCR panels cover a wide range of pathogens in dogs and cats, enabling accurate diagnosis of gastrointestinal, respiratory, and systemic diseases.According to WHO, improving early disease detection in pets supports antimicrobial stewardship and zoonosis prevention at the household level.
Zoetis Inc. (11-14%)
Zoetis offers molecular diagnostics integrated with its broader animal health ecosystem. Its VetScan platform and reference lab offerings support rapid, species-specific pathogen detection in both small and large animals.According to UN, molecular tools for animal disease control are essential for strengthening global veterinary infrastructure and biosecurity.
Thermo Fisher Scientific (9-12%)
Thermo Fisher provides high-sensitivity PCR assays and automated instruments for a range of veterinary applications, including poultry, cattle, and aquaculture health monitoring. Its tools are widely adopted in research and production systems.According to OECD, molecular diagnostic access for livestock helps safeguard public health and ensure sustainable food production.
Bio-Rad Laboratories, Inc. (7-10%)
Bio-Rad delivers advanced molecular technologies including qPCR and ddPCR for detecting hard-to-diagnose pathogens in equine, bovine, and exotic animals. Its solutions support both laboratory and mobile diagnostics.According to WHO, enhanced molecular surveillance contributes to early outbreak detection and veterinary public health interventions.
QIAGEN N.V. (6-9%)
QIAGEN supplies sample preparation, pathogen detection panels, and automation solutions for veterinary testing labs and field services. Its modular systems offer scalable workflows for clinics, universities, and government programs.According to World Bank Report, diagnostics for animal health contribute significantly to national disease monitoring and trade compliance.
Other Key Players (38-45% Combined)
Numerous diagnostic companies and regional biotech firms offer molecular veterinary testing tools tailored to specific animal populations. These include:
The overall market size for the veterinary molecular diagnostics market was approximately USD 236.8 million in 2025.
The veterinary molecular diagnostics market is expected to reach approximately USD 448.7 Million by 2035.
The demand for veterinary molecular diagnostics is rising due to the increasing prevalence of zoonotic diseases, growing awareness among pet owners about animal health, and advancements in molecular diagnostic techniques. The rising demand for animal-derived food products and the need for early disease diagnosis in livestock have also contributed to the growth of this market.
The top 5 countries driving the development of the veterinary molecular diagnostics market are the United States, Germany, France, Japan, and China.
PCR kits and veterinary hospitals are expected to command significant shares over the assessment period.
Explore In-vitro Diagnostics Devices Insights
Veterinary Molecular Diagnostics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
